Impaired insulin synthesis is accompanied by hyperglycemia and the development of diabetic cardiomyopathy. Echocardiography and left-ventricular catheterization were employed for studying the contractile function of the left ventricle in 2 weeks after administration of streptozotocin (60 mg/kg). The results obtained by both methods were similar and indicated the development of systolic dysfunction with a 27% decrease in cardiac output. The invasive study showed that the maximum rate of left-ventricular pressure development, the contractility index, and systolic left-ventricular pressure were within the normal range, but the peak ejection rate was reduced by 28%. BP was normal, but the vascular stiffness index was increased by about 1.5 times and inversely correlated with the peak ejection rate (r=-0.69). The results showed that systolic dysfunction in type 1 diabetes model was due to reduced ejection from the left ventricle at normal rate of left-ventricular pressure development.
Similar content being viewed by others
References
Abramov AA, Lakomkin VL, Prosvirnin AV, Kapelko VI. Pressure and volume characteristics of the left ventricle in its diastolic and systolic dysfunction. Kardiologiya. 2019;59(4):45- 51. doi: https://doi.org/10.18087/cardio.2019.4.2647. Russian.
An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2006;291(4):H1489-H1506. doi: https://doi.org/10.1152/ajpheart.00278.2006
Borges GR, de Oliveira M, Salgado HC, Fazan R Jr. Myocardial performance in conscious streptozotocin diabetic rats. Cardiovasc. Diabetol. 2006;5:26. doi: https://doi.org/10.1186/1475-2840-5-26
Ceriello A, Quagliaro L, D’Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002;51(4):1076-1082. doi: https://doi.org/10.2337/diabetes.51.4.1076
Cosson S, Kevorkian JP. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? Diabetes Metab. 2003;29(5):455-466. doi: https://doi.org/10.1016/s1262-3636(07)70059-9
Dillmann WH. Diabetic cardiomyopathy: what is it and can it Be fixed? Circ. Res. 2019;124(8):1160-1162. doi: https://doi.org/10.1161/CIRCRESAHA.118.314665
Fein FS, Kornstein LB, Strobeck JE, Capasso JM, Sonnenblick EH. Altered myocardial mechanics in diabetic rats. Circ. Res. 1980;47(6):922-933. doi: https://doi.org/10.1161/01.res.47.6.922
Joffe II, Travers KE, Perreault-Micale CL, Hampton T, Katz SE, Morgan JP, Douglas PS. Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. J. Am. Coll. Cardiol. 1999;34(7):2111-2119. doi: https://doi.org/10.1016/s0735-1097(99)00436-2
Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. J. Clin. Invest. 1990;86(2):481-488. doi: https://doi.org/10.1172/JCI114734
Schnell O, Cappuccio F, Genovese S, Standl E, Valensi P, Ceriello A. Type 1 diabetes and cardiovascular disease. Cardiovasc. Diabetol. 2013;12:156. doi: https://doi.org/10.1186/1475-2840-12-156.
Severson DL. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can. J. Physiol. Pharmacol. 2004;82(10):813-823. doi: https://doi.org/10.1139/y04-065
Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes. 2002;51(4):1166-1171. doi: https://doi.org/10.2337/diabetes.51.4.1166
Waczulíková I, Cagalinec M, Uličná O, Slezák P, Ziegelhöffer A. Biophysical investigation on left ventricular myocytes in rats with experimentally induced diabetes. Physiol. Res. 2010;59(Suppl 1):S9-S17. doi: https://doi.org/10.33549/physiolres.932011
Waddingham MT, Edgley AJ, Tsuchimochi H, Kelly DJ, Shirai M, Pearson JT. Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy. World J. Diabetes. 2015;6(7):943-960. doi: https://doi.org/10.4239/wjd.v6.i7.943
Zhang L, Cannell MB, Phillips AR, Cooper GJ, Ward ML. Altered calcium homeostasis does not explain the contractile deficit of diabetic cardiomyopathy. Diabetes. 2008;57(8):2158- 2166. doi: https://doi.org/10.2337/db08-0140
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 172, No. 7, pp. 20-24, July, 2021
Rights and permissions
About this article
Cite this article
Lakomkin, V.L., Abramov, A.A., Lukoshkova, E.V. et al. Systolic Dysfunction of the Heart in Type 1 Diabetes Mellitus. Bull Exp Biol Med 172, 14–17 (2021). https://doi.org/10.1007/s10517-021-05321-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05321-1